Hacker News Reader

Wrong. Gilead made Harvoni. Pharmasset made Sovaldi.

Is there something that’s supposed to be inherently evil in acquiring a company anyway?

Because pharmasset, the smaller company, had forecasted a price of 36000$ for Solvadi. With Gilead buying it out, it was able to reach a third of that price point and that’s a win to me.

View on HN

Harvoni is a combination of Sofosbuvir (Sovaldi) and Ledipasvir.

Pharmasset discovered Sofosbuvir (Sovaldi), Gilead acquired them in 2011.

Gilead developed Ledipasvir some time after that.

I was contesting the phrase "literally made a cure for a previously uncureable disease". Which is why I called out the acquisition. They literally bought it, not made it.

Here in Canada there is some debate over sofosbuvir and velpatasvir their cost. A person may be cured of hepatitis C in just a few months. That would be fantastic for them since done soon enough may prevent liver fibrosis. And really for the tax payers here in socialized medical land it saves money by not treating infected people for decades.

> Is there something that’s supposed to be inherently evil in acquiring a company anyway?

See the fable the little red hen. It's work ethics.

https://en.wikipedia.org/wiki/The_Little_Red_Hen

Reply on news.ycombinator.com